Skip to main content

Together we are beating cancer

Donate now

Bladder cancer

Showing 12 out of 47 results

According to new research, a simple urine test could distinguish between aggressive and less aggressive bladder cancers. According to new research, a simple urine test could distinguish between aggressive and less aggressive bladder cancers.

by Cancer Research UK | News | 29 November 2013

29 November 2013

Radiotherapy is an effective treatment for aggressive bladder cancer and could spare patients surgery that removes the whole bladder. Radiotherapy is an effective treatment for aggressive bladder cancer and could spare patients surgery that removes the whole bladder.

by Cancer Research UK | News | 1 October 2013

1 October 2013

Cancer Research UK logo

Up to 700 women in England diagnosed with kidney or bladder cancer every year are experiencing a delay in being referred to a specialist, new research has revealed. Up to 700 women in England diagnosed with kidney or bladder cancer every year are experiencing a delay in being referred to a specialist, new research has revealed.

by In collaboration with PA Media Group | News | 24 June 2013

24 June 2013

Cancer Research UK logo

Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy.

by British Journal of Cancer | News | 17 April 2013

17 April 2013

Cancer Research UK logo

Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research today, (Friday). Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research today, (Friday).

by Cancer Research UK | News | 1 March 2013

1 March 2013

Cancer Research UK logo

Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to those given radiotherapy alone, a major trial funded by Cancer Research UK shows today (Wednesday). Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to those given radiotherapy alone, a major trial funded by Cancer Research UK shows today (Wednesday).

by Cancer Research UK | News | 18 April 2012

18 April 2012